DP-9024, an investigational small molecule modulator of the integrated stress response kinase GCN2, synergizes with asparaginase therapy in leukemic tumors

被引：0
|
作者：
Al-Ani, Gada
Elliott, Kristin M.
Groer, Qi
Rudeen, Aaron J.
Kearney, Patrick C.
Zwicker, Jeffery D.
Ahn, Yu Mi
Bulfer, Stacie L.
Heiniger, Cale L.
Hood, Molly M.
Javed, Salim
Large, Joshua W.
Petty, Max D.
Stoltz, Kristen L.
Le Bourdonnec, Bertrand
Smith, Bryan D.
Flynn, Daniel L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4938
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4938
引用
收藏
页数：3
相关论文
共 10 条
  • [1] Dimerization-induced activation of the integrated stress response kinase PERK by an investigational small molecule modulator, DP-9024
    Al-Ani, Gada
    Rudeen, Aaron J.
    Groer, Qi
    Elliott, Kristin M.
    Kearney, Patrick C.
    Zwicker, Jeffery D.
    Ahn, Yu Mi
    Bulfer, Stacie L.
    Heiniger, Cale L.
    Hood, Molly M.
    Javid, Salim
    Large, Joshua W.
    Petty, Max D.
    Stoltz, Kristen L.
    Le Bourdonnec, Bertrand
    Smith, Bryan D.
    Flynn, Daniel L.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] DP-9024, an investigational small molecule modulator of the Integrated Stress Response kinase PERK, causes B-cell cancer growth inhibition as single agent and in combination with standard-of-care agents
    Al-Ani, Gada
    Groer, Qi
    Rudeen, Aaron J.
    Elliott, Kristin M.
    Kearney, Patrick C.
    Zwicker, Jeffery D.
    Ahn, Yu Mi
    Bulfer, Stacie L.
    Heiniger, Cale L.
    Hood, Molly M.
    Javed, Salim
    Large, Joshua W.
    Petty, Max D.
    Stoltz, Kristen L.
    Le Bourdonnec, Bertrand
    Smith, Bryan D.
    Flynn, Daniel L.
    CANCER RESEARCH, 2023, 83 (07)
  • [3] DP-9149, an investigational small molecule modulator of the Integrated Stress Response kinase GCN2, pre-clinically causes solid tumor growth inhibition as a single agent and regression in combination with standard of care agents
    Al-Ani, Gada
    Groer, Qi
    Elliott, Kristin M.
    Rudeen, Aaron J.
    Kearney, Patrick C.
    Zwicker, Jeffery D.
    Ahn, Yu Mi
    Bulfer, Stacie L.
    Heiniger, Cale L.
    Hood, Molly M.
    Javid, Salim
    Large, Joshua W.
    Petty, Max D.
    Stoltz, Kristen L.
    Le Bourdonnec, Bertrand
    Smith, Bryan D.
    Flynn, Daniel L.
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Targeting the Integrated Stress Response Kinase GCN2 to Modulate Retroviral Integration
    Torres, Chloe
    Garling, Asja
    Taouji, Said
    Calmels, Christina
    Andreola, Marie-Line
    Metifiot, Mathieu
    MOLECULES, 2021, 26 (17):
  • [5] A novel small molecule activator of the integrated stress response kinase GCN2 shows potent preclinical antitumor activity as monotherapy and in combination with standard of care agents
    Al-Ani, G.
    Groer, Q.
    Eliott, K. M.
    Rudeen, A. J.
    Zwicker, J. D.
    Javed, S.
    Hood, M. M.
    Dhanak, D.
    Flynn, D. L.
    Smith, B. D.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S13 - S14
  • [6] A multicenter, open-label, phase 1a/b study of HC-7366, a modulator of integrated stress response (ISR) kinase GCN2 in subjects with advanced solid tumors
    Pelster, Meredith
    Torre, Marcio
    Kannan, Geoffrey Sumithran
    Gargano, Michele Anne
    Mattson, Paulette
    Rathmann, Blaine
    Bose, Nandita
    Iglesias, Jose Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Targeting GCN2 kinase-driven stress response inactivation by orally available small molecules to restore immune tumor microenvironment in prostate cancers.
    Medley, Kyle
    Li, Zhaoliang
    Yan, Dongqing
    Swami, Umang
    Agarwal, Neeraj
    Vankayalapati, Hariprasad
    CANCER RESEARCH, 2021, 81 (13)
  • [8] Novel inhibitor targeting triple integrated stress response kinase HRI, PERK, and GCN2 provides new insights into overcoming resistance to proteasome inhibitors in multiple myeloma
    Inoue, Yasumichi
    Hikami, Koki
    Ebara, Shunsuke
    Sugiyama, Midori
    Oda, Robert
    Mizutani, Akio
    Yoshida, Misaki
    Yamakawa, Hiroko
    Yagishita, Shigehiro
    Hamada, Akinobu
    Hayashi, Hidetoshi
    Ri, Masaki
    Iida, Shinsuke
    Morishita, Daisuke
    CANCER RESEARCH, 2024, 84 (06)
  • [9] IDO modifies TLR-ligand driven macrophage cytokine production by activation of GCN2 kinase arm of the integrated stress response and subsequent CHOP/GADD153 induction
    Liu, Haiyun
    Bradley, Jill
    Huang, Lei
    McGaha, Tracy
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [10] The Integrated Stress Response kinase GCN2 regulates cell proliferation and survival through combined transcriptional and translational control of p21 (Cip1/Waf1)
    Lehman, Stacey L.
    Ye, Jiangbin
    Koumenis, Constantinos
    CANCER RESEARCH, 2014, 74 (19)
1